13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 2 managers

Reported value

$3.48M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$99K

Price effect on 2 books still in the name

Largest holder

$2.98M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC102.8K$2.98M$75.1KAdded$1.46M
Henshaw Capital LLC17.4K$504.7K$23.9KAdded$23.9K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.